The PaxView SARS-CoV-2 MPCR-ULFA Kit is an in vitro diagnostic kit designed for the qualitative detection of SARS-CoV-2 viral RNA in samples from the upper respiratory tract, such as oropharyngeal or nasopharyngeal swabs.

The PaxView SARS-CoV-2 MPCR-ULFA Kit detects the novel coronavirus, SARS-CoV-2 by one-step RT-PCR in a single tube and a ULFA matrix detection system. The target genes for virus detection are Orf1ab and the N gene. The kit includes primers targeting the human RNase P gene that serves as an internal positive control for multiplex PCR.

Quick and convenient molecular diagnostic kit.

The PaxView SARS-CoV-2 MPCR-ULFA kit is a new diagnostic technology using patented PaxGenBio technology MPCR-ULFA technology (Multiplex Polymerase Chain Reaction – Universal Lateral Flow Test) and is cost-effective and convenient consisting of the MPCR kit and the ULFA kit.

Features and Advantages

  • One-step RT-PCR in a single tube
  • Application of MPCR-ULFA (Multiplex PCR-Universal Lateral Flow Assay), the patented and patented technology by PaxGenBio
  • Simple and easy to use method
  • Easy to use and a visual check of results (10 to 15 minutes)
  • Orf1ab target genes and N gene
  • The limit of detection (LoD) is 50 copies / reaction
  • Monitor the entire process, including sample collection, RNA extraction and RT-PCR using internal control, human gene Rnase P

Related Post

Leave a Reply

Your email address will not be published. Required fields are marked *